Cargando…

Regulatory post‐market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies

Information on rare adverse effects is often limited when a medication is initially approved for marketing. Medicines regulators use safety advisories to warn health professionals and consumers about emerging harms. This study aimed to identify characteristics and advice provided in cardiac safety a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hooimeyer, Ashleigh, Bhasale, Alice, Perry, Lucy, Fabbri, Alice, Mohammad, Annim, McEwin, Eliza, Mintzes, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652786/ https://www.ncbi.nlm.nih.gov/pubmed/33169534 http://dx.doi.org/10.1002/prp2.680

Ejemplares similares

Association Between Conflicts of Interest and Authors’ Positions on Harms of Varenicline: a Cross-Sectional Analysis
por: Fabbri, Alice, et al.
Publicado: (2021)

Interactions between Australian cancer physicians and the pharmaceutical industry: a qualitative study
por: Pokorny, Adrian M J, et al.
Publicado: (2023)

Epidemiological studies for regulatory agencies.
por: Hunt, V R
Publicado: (1981)

Decisions by regulatory agencies: are they evidence-based?
por: Furberg, Curt D
Publicado: (2007)

A Comparison of Post-marketing Measures Imposed by Regulatory Agencies to Confirm the Tissue-Agnostic Approach
por: Mulder, Jorn, et al.
Publicado: (2022)

Regulatory assessment of nano-enabled health products in public health interest. Position of the scientific advisory board of the French National Agency for the Safety of Medicines and Health Products
por: Oualikene-Gonin, Wahiba, et al.
Publicado: (2023)

Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies
por: Spelsberg, Angela, et al.
Publicado: (2017)

International regulatory agencies: Indian clinical trials
por: Bhatt, Arun
Publicado: (2011)

Regulatory Agencies and PET/CT Imaging in the Clinic
por: Herscovitch, Peter
Publicado: (2022)

Disease Mongering in Drug Promotion: Do Governments Have a Regulatory Role?
por: Mintzes, Barbara
Publicado: (2006)

Regulatory agencies issue advice on use of NSAIDs for COVID-19
Publicado: (2020)

Revolving doors and conflicts of interest in health regulatory agencies in Brazil
por: Scheffer, Mário C, et al.
Publicado: (2020)

Establishment of the African Medicines Agency: progress, challenges and regulatory readiness
por: Ncube, Bakani Mark, et al.
Publicado: (2021)

Regulatory scripting: Stakeholder participation in food and drug administration medical device advisory meetings
por: White, Shelley K., et al.
Publicado: (2023)

Recognising and responding to deteriorating patients: what difference do national standards make?
por: Anstey, Matthew H., et al.
Publicado: (2019)

Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic
por: de Paula, Bruno H R, et al.
Publicado: (2020)

Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World
por: Fernández-Garza, Luis E., et al.
Publicado: (2023)

Time to improve transparency at Health Canada’s Pest Management Regulatory Agency
por: Gagnon, Marc-André, et al.
Publicado: (2023)

Problems in the regulatory policy of the drug market
por: Miziara, Nathália Molleis, et al.
Publicado: (2015)

UK Guidelines on the Diagnosis and Treatment of Breast Implant‐Associated Anaplastic Large Cell Lymphoma on behalf of the Medicines and Healthcare products Regulatory Agency Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group
por: Turton, Philip, et al.
Publicado: (2020)

Teen Advisory Council Survey's Factors Associated With Self-Harming Thoughts
por: McPherson, Pamela, et al.
Publicado: (2022)

Access to regulatory data from the European Medicines Agency: the times they are a-changing
por: Wieseler, Beate, et al.
Publicado: (2012)

Prevalence of severe asthma according to the drug regulatory agency perspective: An Italian experience
por: Vianello, A., et al.
Publicado: (2019)

Regulatory Science to 2025: An Analysis of Stakeholder Responses to the European Medicines Agency's Strategy
por: Hines, Philip A., et al.
Publicado: (2020)

Evaluation of the Performance of the Turkish Regulatory Agency: Recommendations for Improved Patients’ Access to Medicines
por: Koyuncu, Oguzhan, et al.
Publicado: (2020)

Building organizational reputation in the European regulatory state: An analysis of EU agencies' communications
por: Rimkutė, Dovilė
Publicado: (2019)

Contribution of Real‐World Evidence in European Medicines Agency's Regulatory Decision Making
por: Bakker, Elisabeth, et al.
Publicado: (2022)

Effects of Four Different Regulatory Mechanisms on the Dynamics of Gene Regulatory Cascades
por: Hansen, Sabine, et al.
Publicado: (2015)

Regulatory requirements for marketing fixed dose combinations
por: Jayasheel, B. G.
Publicado: (2010)

Research opportunities in the regulatory aspects of electronic markets
por: Clarke, Roger
Publicado: (2021)

The Role of Regulatory Sciences from the Perspective of the Cuban Medicines Regulatory Agency: The Impact of COVID-19 in Promoting Innovation, Cooperation and Scientific Thinking
por: Romeu, Belkis, et al.
Publicado: (2021)

Comparison of pharmacogenomic information for drug approvals provided by the national regulatory agencies in Korea, Europe, Japan, and the United States
por: Lee, Mijin, et al.
Publicado: (2023)

Real-world evidence (RWE): A challenge for regulatory agencies discussion of the RWE conference with the network of the european medicine agencies, patients, and experts
por: Maison, Patrick, et al.
Publicado: (2022)

Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies
por: Lehoux, Pascale, et al.
Publicado: (2017)

Evaluation of the Performance of the South Africa Regulatory Agency: Recommendations for Improved Patients’ Access to Medicines
por: Keyter, Andrea, et al.
Publicado: (2019)

Self-Harming and Sense of Agency in Patients With Borderline Personality Disorder
por: Colle, Livia, et al.
Publicado: (2020)

Bringing cultured meat to market: Technical, socio-political, and regulatory challenges in cellular agriculture
por: Stephens, Neil, et al.
Publicado: (2018)

A Proposed Regulatory Review Model to Support the South African Health Products Regulatory Authority to Become a More Efficient and Effective Agency
por: Keyter, Andrea, et al.
Publicado: (2020)

Drug Lag and Key Regulatory Barriers in the Emerging Markets
por: Wileman, Harriet, et al.
Publicado: (2010)

Live bird market in Bangladesh: Regulatory systems and operations
por: Irin, Nusrat, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_olt636pvap2opm7eocqonkbomu